Capitolis Liquid Global Markets LLC Abb Vie Inc. Transaction History
Capitolis Liquid Global Markets LLC
- $10.3 Trillion
- Q4 2024
A detailed history of Capitolis Liquid Global Markets LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Capitolis Liquid Global Markets LLC holds 650,000 shares of ABBV stock, worth $131 Million. This represents 1.13% of its overall portfolio holdings.
Number of Shares
650,000
Previous 810,000
19.75%
Holding current value
$131 Million
Previous $160 Billion
27.79%
% of portfolio
1.13%
Previous 1.7%
Shares
4 transactions
Others Institutions Holding ABBV
# of Institutions
4,095Shares Held
1.28BCall Options Held
16.7MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$35 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.6 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$16.1 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10.5 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$8.02 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $357B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...